Top Markets
Coin of the day
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Zhejiang AngLiKang Pharmaceutical CO.,LTD.

Zhejiang AngLiKang Pharmaceutical CO.,LTD.

002940
Rang in Aktien #11260
Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on... Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on the manufacturing and distribution of various pharmaceutical goods. Their operations span the production and sale of active pharmaceutical ingredients (APIs), finished drug formulations, and empty capsules for medical use. The company's existing product line encompasses treatments for a variety of conditions, including anti-infective agents, antihypertensives for blood pressure management, medications for digestive system health, and respiratory preparations. Beyond its current offerings, AngLiKang is also deeply involved in drug research and development. Their R&D efforts are concentrated on creating new therapies, with a particular emphasis on oral cephalosporin antibiotics, as well as treatments for cardiovascular, renal (kidney), and central nervous system diseases. The company was established in 2001 and maintains its headquarters in Shengzhou, China.
Aktienkurs
$3.69
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$722.97M
Veränderung (1 Tag)
-1.62%
Veränderung (1 Jahr)
-46.81%
Land
CN
Handel Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940)

Kategorie

Kursverlauf für Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940)
Höchster Schlusskurs: $3.83 am 2026-08-01

Niedrigster Schlusskurs: $2.96 am 2018-10-01
Kursverlauf der Aktie von Zhejiang AngLiKang Pharmaceutical CO.,LTD. von 2018 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -1.84%
2025 156.96%
2024 -34.44%
2023 5.88%
2022 13.24%
2021 -21.48%
2020 57.02%
2019 -26.75%
2018 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$166.36 31.46%
DE
$37.84 25.87%
JP
$222.33 27.49%
CH
$21.19 17.16%
IN